Suppression of Non-Small Cell Lung Cancer Growth and Metastasis by a Novel Small Molecular Activator of RECK

Conclusion: These findings identify Harmine as a promising activator of RECK signaling for metastatic NSCLC treatment.Cell Physiol Biochem 2018;45:1807 –1817

https://www.karger.com/Article/FullText/487872

Source: Cellular Physiology and Biochemistry - March 6, 2018 Category: Cytology Source Type: research